Related Experiment Video

Updated: Aug 11, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae

Y Fukuda1, K Yanagihara, Y Higashiyama

  • 1Second Dept of Internal Medicine, Nagasaki University School of Medical Sciences, Sakamoto, Nagasaki, Japan.

The European Respiratory Journal
|February 4, 2006
PubMed

Insights

Sub-minimum inhibitory concentrations of macrolides, including clarithromycin (CLR) and azithromycin (AZM), effectively reduced pneumolysin production and activity in macrolide-resistant Streptococcus pneumoniae. This finding may explain the clinical effectiveness of macrolides in treating pneumonia caused by resistant strains.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Increasing resistance to macrolides in Streptococcus pneumoniae poses a clinical challenge.
  • The conservative clinical effects of macrolides despite rising resistance warrant further investigation.
  • Pneumolysin, a toxin produced by S. pneumoniae, is a key virulence factor.

Purpose of the Study:

  • To evaluate the impact of sub-minimum inhibitory concentrations of macrolides on pneumolysin production and activity.
  • To investigate the in vitro and in vivo effects of clarithromycin (CLR) and azithromycin (AZM) on macrolide-resistant S. pneumoniae.
  • To explore the potential mechanisms behind the clinical efficacy of macrolides against resistant pneumococcal infections.

Main Methods:

  • In vitro incubation of S. pneumoniae with varying concentrations of CLR and AZM.
  • Western blot analysis and haemolytic assays to assess pneumolysin production and activity.
  • In vivo mouse model of S. pneumoniae infection treated with CLR and AZM, followed by lung tissue analysis and survival rate monitoring.

Main Results:

  • All tested macrolide concentrations inhibited pneumolysin production in vitro.
  • Specific concentrations of CLR and AZM reduced pneumolysin activity in vitro.
  • In vivo, macrolide treatment reduced pneumolysin levels in mouse lungs.
  • CLR and AZM treatment improved survival rates in infected mice.

Conclusions:

  • Sub-minimum inhibitory concentrations of macrolides significantly reduce pneumolysin.
  • This reduction in pneumolysin may contribute to the observed clinical effectiveness of macrolides against macrolide-resistant S. pneumoniae.
  • Further research is needed to fully elucidate the effects of macrolides on resistant strains.

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...